Delcath Systems Inc. (NASDAQ:DCTH) traded up 27.3% during trading on Thursday . The stock traded as high as $4.49 and last traded at $3.87, with a volume of 259,251 shares. The stock had previously closed at $3.04.

The firm’s market capitalization is $5.91 million. The company has a 50 day moving average of $3.93 and a 200-day moving average of $4.75.

Delcath Systems (NASDAQ:DCTH) last issued its quarterly earnings results on Wednesday, May 4th. The medical device company reported ($0.08) earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of ($0.19) by $0.11. Equities analysts forecast that Delcath Systems Inc. will post ($7.84) EPS for the current fiscal year.

Delcath Systems, Inc is a late-stage clinical development company with early commercial activity in Europe focused on cancers of the liver. The Company is a specialty pharmaceutical and medical device company developing its product, Melphalan Hydrochloride for Injection for use with the Delcath Hepatic Delivery System (Melphalan/HDS).

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with's FREE daily email newsletter.